Skip to main content
. 2023 Jul 19;50(3):166. doi: 10.3892/or.2023.8603

Figure 7.

Figure 7.

Cell cycle profiles of SK-N-AS and SK-N-BE(2)-C obtained by FACS analysis. Cell cycle distribution of (A) SK-N-AS and (B) SK-N-BE(2)-C neuroblastoma cell lines treated with WEE1 inhibitor MK-1775 and PARP inhibitor BMN673 for 48 h. BMN, BMN673; MK, MK-1775; WEE1, WEE1 G2 checkpoint kinase; PARP, poly-ADP-ribose-polymerase.